Please assess the completion status of the following clinical trial:

Trial Title: Effect of Lifitegrast on Dry Eye Disease Signs and Symptoms

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Tear Osmolarity \> 320 mOsm/L~* VAS eye dryness \> 40~* No other ocular pathology~* No contact lens wear~* Not currently on T cell modulator~* No change in therapy in last 2 months~* Willingness to adhere to therapy and study visits~* Patients qualified for prescription of lifitegrast drops~Exclusion Criteria:~* Contact lens use~* Eye surgery in Past 6 months~* Use of tear supplements in past 2 hours

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Mild Dry Eye Cohort (Type: ACTIVE_COMPARATOR): Prospective 3 month study of subjects with Tear Osmolarity \>308 and VAS eye dryness ≥ 40 using 5% Lifitegrast ophthalmic solution BID.
- Moderate to Severe Dry Eye Cohort (Type: ACTIVE_COMPARATOR): Prospective 3 month study of subjects with Tear Osmolarity \>320 and VAS eye dryness ≥ 40 using 5% Lifitegrast ophthalmic solution BID.

Based on this trial design, predict the completion outcome and termination type (if applicable).